Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
1(10%)
Results Posted
0%(0 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_3
2
20%
Ph phase_4
3
30%
Ph not_applicable
3
30%
Ph phase_2
2
20%

Phase Distribution

0

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
2(20.0%)
Phase 3Large-scale testing
2(20.0%)
Phase 4Post-market surveillance
3(30.0%)
N/ANon-phased studies
3(30.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(5)
Terminated(2)
Other(2)

Detailed Status

Completed5
Terminated1
Suspended1
Withdrawn1
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (20.0%)
Phase 32 (20.0%)
Phase 43 (30.0%)
N/A3 (30.0%)

Trials by Status

terminated110%
suspended110%
withdrawn110%
unknown110%
completed550%
recruiting110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10